Ovid Therapeutics, Inc. (OVID)
1.705
+0.06
(+3.33%)
USD |
NASDAQ |
Dec 12, 09:31
Ovid Therapeutics Research and Development Expense (TTM): 24.66M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| AnaptysBio, Inc. | 152.43M |
| Ionis Pharmaceuticals, Inc. | 879.75M |
| MannKind Corp. | 49.90M |
| Cassava Sciences, Inc. | 43.27M |
| Cidara Therapeutics, Inc. | 131.82M |